Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
3562 | IL3 | interleukin 3 | |
3565 | IL4 | interleukin 4 | |
3586 | IL10 | interleukin 10 | |
3596 | IL13 | interleukin 13 | |
3597 | IL13RA1 | interleukin 13 receptor subunit alpha 1 | |
3605 | IL17A | interleukin 17A | |
3654 | IRAK1 | interleukin 1 receptor associated kinase 1 | |
3689 | ITGB2 | integrin subunit beta 2 | |
3791 | KDR | kinase insert domain receptor | |
4049 | LTA | lymphotoxin alpha |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
16153 | Il10 | interleukin 10 | |
16163 | Il13 | interleukin 13 | |
16164 | Il13ra1 | interleukin 13 receptor, alpha 1 | |
16171 | Il17a | interleukin 17A | |
16183 | Il2 | interleukin 2 | |
16187 | Il3 | interleukin 3 | |
16189 | Il4 | interleukin 4 | |
16414 | Itgb2 | integrin beta 2 | |
16542 | Kdr | kinase insert domain protein receptor | |
16592 | Fabp5 | fatty acid binding protein 5, epidermal |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24267 | Comt | catechol-O-methyltransferase | |
24296 | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 | |
24787 | Sod2 | superoxide dismutase 2 | |
24835 | Tnf | tumor necrosis factor | |
24854 | Clu | clusterin | |
25008 | Lta | lymphotoxin alpha | |
25325 | Il10 | interleukin 10 | |
25419 | Crp | C-reactive protein | |
25464 | Icam1 | intercellular adhesion molecule 1 | |
25589 | Kdr | kinase insert domain receptor |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
175182 | ver-1 | Protein ver-1 | |
175504 | pat-3 | Integrin beta pat-3 | |
177314 | gba-4 | Putative glucosylceramidase 4 | |
178535 | gba-3 | Putative glucosylceramidase 3 | |
181289 | ver-3 | Tyrosine-protein kinase receptor ver-3 | |
186632 | ver-4 | Tyrosine-protein kinase receptor ver-4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024